Cargando…
Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19
BACKGROUND: Patients recovering from COVID-19 may need vaccination against SARS-CoV-2 because acquired immunity from primary infection may wane, given the emergence of new SARS-CoV-2 variants. Understanding the trends of anti-spike IgG and neutralizing antibody titers in patients recovering from COV...
Autores principales: | Liu, Wang-Da, Wang, Jann-Tay, Chao, Tai-Ling, Ieong, Si-Man, Tsai, Ya-Min, Kuo, Po-Hsien, Tsai, Ming-Jui, Chen, Yi-Jie, Li, Guei-Chi, Ho, Shu-Yuan, Chen, Hui-Hou, Huang, Yu-Shan, Hung, Chien-Ching, Chen, Yee-Chun, Chang, Sui-Yuan, Chang, Shan-Chwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Formosan Medical Association, Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705194/ https://www.ncbi.nlm.nih.gov/pubmed/36496300 http://dx.doi.org/10.1016/j.jfma.2022.11.015 |
Ejemplares similares
-
Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
por: Liu, Wang-Da, et al.
Publicado: (2021) -
Prolonged virus shedding even after seroconversion in a patient with COVID-19
por: Liu, Wang-Da, et al.
Publicado: (2020) -
Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics
por: Liu, Wang-Da, et al.
Publicado: (2021) -
Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination with a twelve-week interval
por: Sheng, Wang-Huei, et al.
Publicado: (2023) -
Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
por: Cheng, Aristine, et al.
Publicado: (2023)